UNSPSC 51372008: Homprenorphine

This classification denotes an opioid receptor agonist with the molecular formula C28H37NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SH57250J2D, chemically known as 22-cyclopropyl-7alpha-((r)-1-hydroxy-1-methylpropyl)-6,14-endo-ethenotetrahydrothebaine but generally known as homprenorphine, which bears US NIH Compound Identifier 3084250. European Medicines Agency schedules Homprenorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08054MIG.

UNSPSC 51372008 Homoprenorphine, a Commodity code, covers pharmaceutical products for overdose response and drug management that state and local governments procure to support community health and public safety initiatives. The recent solicitation activity reflects acquisition of naloxone and drug deactivation systems rather than homoprenorphine narrowly defined, indicating that state and local procurement offices use this code to classify a broader family of overdose-response pharmaceuticals and related harm-reduction products. Issuing bodies under this code include county health departments and community health agencies that support opioid crisis response programs and public-health infrastructure.

Seminole County, Florida posted an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2026. The contract carries a two-year initial term with an optional one-year renewal, includes E-Verify compliance and drug-free workplace certification requirements, and may be FEMA-funded. The procurement is geographically concentrated in Florida based on available records, though activity under this Commodity code appears limited in recent state and local posting activity.